产品介绍 评论(0)
物种
Human分子别名
HGFIN, NMB, OsteoactivinAccession
Q14956表达序列
Lys23-Asn498, with C-terminal His表达宿主
HEK293分子量
80-95kDa (Reducing)纯度
>95% by SDS-PAGE内毒素含量
<0.1EU/μg标记
Unconjugated标签
His Tag性状
Lyophilized Powder缓冲体系
PBS, pH7.4.溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.文献引用
1.Hassan Ashktorab, Hamed Rahi. GPNMB methylation: a new marker of potentially carcinogenic colon lesions. BMC Cancer 2018 Nov 6;18(1):1068.
GlycoProtein Non-metastatic Melanoma B (GPNMB)was discovered in 1995, through a study on two melanoma cell lines with low and high metastatic abilities. The authors determined and characterized GPNMB cDNA that was highly expressed in the low metastatic cell line. GPNMB is located on the short arm of chromosome 7 (7p15) and known as neurokinin-1 type, hematopoietic growth factor inducible (HGFIN). It is a type I transmembrane protein that has three unique domains: an extracellular, a transmembrane, and a cytoplasmic one. The extracellular domain consists of two regions with different properties, an integrin-binding motif (RGD) and a polycystic kidney disease (PKD) domain. The cytoplasmic tail has two functionally different parts including a dileucine-based sorting signal and a half immunoreceptor tyrosine-based activation motif(hemITAM).
电泳
1μg (R: reducing condition, N: non-reducing condition).







评论(0)